Gsk (GSK) Profit After Tax (2009 - 2026)

Gsk (GSK) has 18 years of Profit After Tax data on file, last reported at $3.2 billion in Q3 2026.

• For the quarter ending Q3 2026, Profit After Tax changed N/A year-over-year to $3.2 billion; the trailing twelve-month figure through Sep 2026 stood at $10.4 billion (changed N/A YoY), and the FY2025 full-year result was $8.4 billion, up 121.77% from the prior year.
• Profit After Tax was $3.2 billion for Q3 2026 at Gsk, up from $208.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $4.5 billion in Q4 2025 to a low of $81.9 million in Q3 2024.
• A 5-year average of $2.3 billion and a median of $2.2 billion in 2025 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax tumbled 96.1% in 2024 and jumped 4462.94% in 2025, its largest moves.
• Gsk's Profit After Tax stood at $3.0 billion in 2022, then soared by 41.93% to $4.2 billion in 2023, then slipped by 26.94% to $3.1 billion in 2024, then soared by 48.52% to $4.5 billion in 2025, then declined by 29.36% to $3.2 billion in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were $3.2 billion in Q3 2026, $208.0 million in Q2 2026, and $2.5 billion in Q1 2026.